Tax-driven stock sales by Aveanna (AVAH) CAO Edwin C. Reisz

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Chief Administrative Officer Edwin C. Reisz reported three open-market sales of common stock in mid-February 2026, totaling 162,043 shares. The transactions covered 42,057 shares at $7.6451, 59,217 shares at $7.3829, and 60,769 shares at $7.2082 per share. According to the disclosure, these shares were automatically sold to satisfy his tax obligations related to recently vested equity awards. After these sales, Reisz directly owned 1,447,057 Aveanna shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reisz Edwin C.

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Administrative Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/17/2026		S(1)		42,057	D	$7.6451(2)	1,567,043	D
Common Stock, par value $0.01 per share	02/18/2026		S(1)		59,217	D	$7.3829(3)	1,507,826	D
Common Stock, par value $0.01 per share	02/19/2026		S(1)		60,769	D	$7.2082(4)	1,447,057	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.

2. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.47 to $7.97. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	/s/ Jonathan Beckler, Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aveanna Healthcare (AVAH) report for Edwin C. Reisz?

Aveanna Healthcare reported that Chief Administrative Officer Edwin C. Reisz sold 162,043 shares of common stock in three open-market transactions. These trades occurred in mid-February 2026 and were related to the vesting of equity awards and associated tax obligations.

Were Edwin C. Reisz’s AVAH share sales discretionary or tax-related?

The reported Aveanna share sales were tax-related, not discretionary selling for portfolio reasons. The filing states the shares were automatically sold to satisfy Reisz’s tax obligations arising from shares issued upon vesting of previously reported equity awards.

At what prices did Aveanna CAO Edwin C. Reisz sell AVAH shares?

Reisz’s reported Aveanna stock sales were executed at weighted average prices of $7.6451, $7.3829, and $7.2082 per share. Footnotes note each line reflects multiple trades within specified price ranges managed by the company’s stock plan administrator.

How many Aveanna (AVAH) shares does Edwin C. Reisz hold after the Form 4 sales?

Following the reported tax-related sales, Edwin C. Reisz directly owns 1,447,057 shares of Aveanna common stock. This post-transaction balance reflects all three mid-February 2026 open-market sales disclosed in the Form 4 filing.

Over what period did Aveanna CAO Reisz sell the 162,043 AVAH shares?

The 162,043 Aveanna shares were sold over three trading days in February 2026. Transactions occurred on February 17, 18, and 19, with each day’s activity reported separately but all tied to equity award vesting and related tax obligations.

Who executed the Aveanna (AVAH) share sales reported for Edwin C. Reisz?

The trades were executed as part of aggregate sales by Aveanna’s stock plan administrator. The filing explains that the administrator conducted the open-market sales to automatically cover Reisz’s tax obligations from vested equity awards, using weighted average pricing.